Employer record no. 3725
CRISPR Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
127
Certified
114
Denied
2
FY2025 filings
18
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#247 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 16 | 16 | 0 | $110,011 | $92,663 |
| FY2021 | 14 | 14 | 0 | $115,697 | $104,804 |
| FY2022 | 20 | 20 | 0 | $114,337 | $102,225 |
| FY2023 | 18 | 18 | 0 | $113,356 | $99,238 |
| FY2024 | 29 | 21 | 2 | $117,788 | $101,466 |
| FY2025 | 18 | 13 | 0 | $126,645 | $110,788 |
| FY2026 * | 12 | 12 | 0 | $258,129 | $128,813 |
What they file for
- research associate ii$84,72219
- senior research associate$101,49517
- principal research associate$118,5407
- senior research associate, analytical development$101,7337
- manager, qa operations$124,2504
- scientist ii$136,1564
- research associate ii, analytical development$83,2863
- scientist$114,3133
Where
- boston, ma74
- cambridge, ma49
- san francisco, ca2
- shrewsbury, ma1
- south san francisco, ca1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for CRISPR Therapeutics, Inc. and any other employer they watch.
Certification rate 89.8%How these numbers are computed